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Acute insult to the myocardium is associated with substantial loss of cardiomyocytes during the
process of myocardial infarction. In this setting, apoptosis (programmed cell death) and necrosis may
operate on a continuum. Because the latter is characterized by the loss of sarcolemmal integrity, we propose
that an appropriately labeled tracer directed at a ubiquitously present intracellular moiety would
allow non-invasive definition of cardiomyocyte necrosis. A trivalent arsenic peptide, GSAO
(4-(N-(S-glutathionylacetyl)amino)phenylarsonous acid), is capable of binding to intracellular dithiol
molecules such as HSP90 and filamin-A. Since GSAO is membrane impermeable and dithiol molecules
abundantly present intracellularly, we propose that myocardial localization would represent sarcolemmal
disruption or necrotic cell death. In rabbit and mouse models of myocardial infarction and post-infarct
heart failure, we employed In-111-labelled GSAO for noninvasive radionuclide molecular imaging.
111In-GSAO uptake was observed within the regions of apoptosis seeking agent- 99mTc-Annexin A5 uptake,
suggesting the colocalization of apoptotic and necrotic cell death processes.
C
ell death plays a central role in various cardiovascular diseases. Twomorphologically distinct modes of cell
death - apoptosis (a programmed process characterized by enzymatic degradation and clean removal of
the cell) and necrosis (an uncontrolled process characterized by cell swelling, membrane rupture and spill
of its contents) have been reported to contribute to the myocardial tissue loss. It is being increasingly realized that
apoptosis and necrosis, rather than being entirely independent, may operate on a continuum, at least in response
to noxious stimuli1–3.
Numerous strategies have been proposed for the detection of cell death early after onset of ischemia within the
time window amenable to intervention. Most experience for the recognition of apoptosis has been obtained with
single photon emission computed tomography (SPECT) imaging using 99mTc-Annexin A5 (AA5). 99mTc-AA5
targets externalized phosphatidylserine (PS) on membranes of cells with active apoptotic signaling4 and the
clinical feasibility of 99mTc-AA5 imaging has been demonstrated in the setting of myocardial infarction5,6, trans-
plant rejection7 and heart failure8. On the other hand, several radiotracers targeting necrotic cells through
membrane disruption have been developed9–11. Notably, antimyosin antibody imaging has been successfully
employed for the detection of myocardial necrosis associated with myocardial infarction (MI)9, myocarditis9,
heart failure12 and cardiac allograft rejection12. However due to technical disadvantages, the necrosis-avid radio-
tracers have not become popular.
4-(N-(S-glutathionylacetyl)amino)phenylarsonous acid (GSAO) labelled with fluorophores and radionuclides
has been used for targeting of cell death in culture, in tumor-bearing mice, and in mice with experimental brain
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trivalent arsenic moiety. The arsenic group binds to dithiols, which are
abundantly present in intracellular milieu and virtually absent from
the extracellular space16. GSAO cannot reach its intracellular target
molecules in intact cells, because it is not able to negotiate across the
cell membrane17. Cell membrane c-glutamyl transferase (GGT) is
upregulated during ischemic stress and other situations, splices off
GSAO’s glutamyl residue and allows cellular entrance of GSAO’s
metabolite GCAO (4-(N-(S-cysteinylglycylacetyl)amino) phenylarso-
nous acid)17. However, when radioactive or fluorescent reporter
molecules are attached to glutamyl residue of GSAO it is not able
to bind to GGT, rendering the molecule membrane impermeable13.
After the necrotic process sets in and the sarcolemmal integritiy is
lost; and GSAO gains free entry to the intracellular microenviron-
ment. Of numerous dithiol-bearing intracellular targets including
filamin A, eukaryotic translation elongation factor 2, and protein
disulfide isomerase (PDI), HSP90 is most widely present13. HSP90
comprises approximately 2% of the intracellular protein content and
increases by two-threefold in response to acute stress including
ischemia18.
In this study we evaluated feasibility of cell death imaging using
111In-GSAO in mouse and rabbit models of acute MI and a mouse
model of chronic MI. In addition, a subgroup of animals,
serial SPECT/CT imaging using 99mTc-AA5 and 111In-GSAO was
performed to determine the relationship between these two modes
of cell death in the setting of myocardial ischemia and reperfusion.
Fluorescent GSAO and AA5 were employed in another subgroup of
animals for pathological characterization of themode of cell death. In
addition, 111In-GSCA (4-(N-(S-glutathionylacetyl)amino)benzoic
acid), which is identical to 111In-GSAO except for replacement of
the arsenic group with a carboxylic acid group, was used as a negative
control compound in radionuclide experiments.
Results
Fluorescence microscopic characterization of GSAO uptake.
Uptake characteristics of GSAO were evaluated and compared
with AA5 in mice with acute MI and sham-operated mice.
Experimental acute MI was induced by 30-minute coronary
ligation followed by 30 minutes of reperfusion. Sham procedure
was identical, except that coronary ligation was not performed.
Mice with acute MI (n 5 3) and sham-operated mice (n 5 3) were
injected Cy5.5-labelled GSAO and Oregon Green-labeled AA5.
Qualitative fluorescent microscopic analysis of heart sections
showed that cardiomyocytes of sham-operated mice were positive
neither for GSAO nor for AA5. In contrast, in ischemia/reperfusion-
injured hearts, cardiomyocytes positive for GSAO and AA5
were observed (Fig. 2a–c). Interestingly, all GSAO-positive
Figure 1 | Targeting mechanism of GSAO. GSAO binds to dithiol molecules, which are abundant in the intracellular space and virtually absent in the
extracellular space. When labelled with radioactive or fluorescent reporter molecules, GSAO cannot negotiate across the cell membrane of healthy
cells (a) but gains free access through disrupted membranes of dying cells (b). Thus, GSAO accumulates in dying cells.
www.nature.com/scientificreports
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cardiomyocytes bound AA5 (Fig. 2a–c), suggesting that necrosis in
the reperfusedmyocardium coexists with apoptotic signaling. Not all
AA5 positive cardiomyocytes had taken up GSAO (Fig. 2c).
Radiolabelled GSAO imaging in acute myocardial infarction.
Acute MI was induced in rabbits and mice by coronary ligation for
40 and 30 minutes, respectively. Reperfusion was achieved by
removal of the suture and 111In-GSAO was administered thirty
minutes later. Three hours thereafter, in vivo micro-SPECT/micro-
CT imaging was performed, animals were sacrificed and hearts were
explanted. Next, ex vivo SPECT/CT and planar cardiac imaging were
performed. Then, rabbit hearts were cut into ,32 small pieces and
mice hearts were sectioned in three short axis slices: basal (remote
area), middle (border zone) and apical (infarct). Radiotracer uptake
was quantified by c-counting, and myocardial pieces were
histopathologically characterized.
In vivo SPECT/CT imaging inMI rabbits (n5 10) revealed intense
uptake of 111In-GSAO in the apical area (Fig. 3a). Ex vivo SPECT/CT
and planar imaging (Fig 3b) of explanted hearts confirmed intense
apical radiotracer uptake. c-counting confirmed that the 111In-GSAO
uptake in the myocardial infarct was markedly higher than the 111In-
GSAO uptake in the remote region (1.10 6 0.45%ID/g vs 0.03 6
0.01%ID/g, P 5 0.005, Fig. 3c).
To study the specificity of 111In-GSAO, the myocardial uptake of
negative control compound GSCAwas evaluated in acute MI rabbits
(n 5 5). In vivo (Fig. 3a) and ex vivo SPECT/CT imaging and
planar imaging (Fig. 3b) revealed very low cardiac uptake of
GSCA; only slightly increased infarct uptake was observed. This
was confirmed by c-counting; when compared with 111In-GSAO,
111In-GSCA uptake in the infarct area was significantly lower (0.07
6 0.03%ID/g, P 5 0.002, Fig 3c). Although low, GSCA uptake in the
infarct area was higher than in the remote area (0.03 6 0.01%ID/g, P
5 0.043). This demonstrated that the trivalent arsenical group was
necessary for targeting of dying cells. Moreover, myocardial 111In-
GSAO uptake in an unmanipulated control animal was similar to
111In-GSAO uptake in the spared myocardium of the MI rabbits
(0.01%ID/g vs 0.03 6 0.01%ID/g), further supporting specificity of
GSAO.
To evaluate localization of cardiac 111In-GSAO uptake, three of ten
animals receiving 111In-GSAOalso received themyocardial perfusion
tracer 99mTc-sestamibi (MIBI), immediately after coronary ligation.
Serial in vivo SPECT/CT imaging confirmed that 111In-GSAO uptake
was localized in the infarct zone as identified by 99mTc-MIBI per-
fusion defect. Similarly, ex vivo serial SPECT/CT imaging and serial
planar imaging (Fig. 3d) revealed uptake of 111In-GSAO in the infarct
zone as shown by 99mTc-MIBI perfusion defect. In each animal, c-
Counting of 99mTc-MIBI and 111In-GSAO in myocardial sections
confirmed increased uptake of 111In-GSAO in the perfusion defects
as sections with low MIBI uptake showed increased 111In-GSAO
uptake and vice versa (fig 3e). c-counting of all myocardial sections
from the animals receiving both 111In-GSAO and 99mTc-MIBI
revealed an inverse correlation between 111In-GSAO uptake and
99mTc-MIBI uptake (r 5 20.70, P , 0.01, Fig 3f).
Of ten animals receiving 111In-GSAO, three also received 99mTc-
AA5. Serial in vivo SPECT/CT imaging with 111In-GSAO and 99mTc-
AA5 revealed similar area of increased uptake; 111In-GSAO uptake
was more intense than 99mTc-AA5 uptake. This was confirmed by ex
vivo serial SPECT/CT imaging and ex vivo serial planar imaging
(Fig. 3g). Quantitative tracer uptake paralleled the imaging data. In
each animal, in sections with increased 99mTc-AA5 uptake, 111In-
GSAO uptake was also increased (fig. 3h). Using all myocardial sec-
tions in all animals receiving 111In-GSAO and 99mTc-AA5, a strong
correlation between uptake of the radiotracers was observed (r5 0.82,
P, 0.01, Fig 3i). Like the fluorescence experiments, this supports that
secondary necrosis after apoptotic signaling may be the dominant
mode of cell death in myocardial infarction. The 111In-GSAO uptake
in the infarct zone was higher than 99mTc-AA5 uptake, although the
results did not reach statistical significance, due to the small sample
size (1.10 6 0.45%ID/g vs 0.47 6 0.23%, P 5 0.47). Uptake in the
remote area was low for both tracers (0.03 6 0.01%ID/g vs 0.04 6
0.02%ID/g, P 5 NS).
After c-counting myocardial pieces from infarct, border and
remote zones were histologically characterized. Representative
examples of the stainings are given in figure 4a. H&E staining
revealed hypereosinophilic change and contraction band necrosis
in the myocardial sections from the infarct area; the morphological
changes were less frequent in the border zone. The remote area was
morphologically normal. The rate of apoptosis as shown by terminal
deoxyribonucleotide transferase TdT-mediated nick-end labeling
(TUNEL) staining (%area positive, %AP) was higher in the infarct
(2.83 6 1.42%AP) and border zone (2.55 6 1.84%AP) than in the
remote zone (0.02 6 0.0%AP, P , 0.001 for both). The %caspase
positive area was higher in the infarct (1.04 6 0.48%AP) than in the
remote zone (0.466 0.48%AP, P5 0.054). 111In-GSAOuptake in the
myocardial sections showed a direct correlation with TUNEL (r:
0.743, P , 0.001, Fig. 4b) and Caspase-3 (r 5 0.533, P , 0.001,
Fig. 4c) stains, further supporting that necrosis as shown by GSAO is
secondary after apoptotic signaling.
Figure 2 | Characterization of target binding of GSAO. Tissue sections of acute MI mice, injected fluorescently labeled GSAO and AA5. (a, b) GSAO
accumulation (red) was only observed in cells with AA5-positive cell membranes (green). (c) All cells AA5-positive cells were not GSAO positive.
www.nature.com/scientificreports
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The non-target organ distribution of 111In-GSAO and 111In-GSCA
demonstrated kidney to be the major organ of radiation burden and
urine major route of excretion; all other organs revealed minimum
burden for both radiotracers (Supplementary Fig. 1a). Serial blood
samples from six animals revealed bi-exponential blood clearance
with an initial fast component T1/2a of 5.3 min followed by a slower
component T1/2b of 9.7 h; the plateau phase was approached at
15 min (Supplementary Fig. 1b).
In vivo SPECT/CT imaging inmice after acuteMI (n5 6) demon-
strated high 111In-GSAO uptake; the use of CT allowed precise local-
ization of the radioactivity in the infarcted region of the heart
(Fig. 5a,b). Specific apical uptake was confirmed by ex vivo
Figure 3 | 111In-GSAO imaging, quantification and comparison with 99mTc-Annexin A5 and 99mTc-MIBI in rabbits with acute myocardial infarction.
(a) In vivo SPECT (left panels), and fused SPECT/CT images (right panels) in acuteMI rabbits revealed intense 111In-GSAO uptake (top) and onlymodest
uptake of radiotracer control compound 111In-GSCA (bottom). (b) Ex vivo planar images confirmed intense 111In-GSAO uptake (top) and modest 111In-
GSCA (bottom) uptake. (c) c-counting of myocardial sections confirmed 111In-GSAO uptake in infarct was higher than in remote area and higher than
111In-GSCA uptake in infarct. Although low, 111In-GSCA uptake in infarct was higher than remote. Difference Between 111In-GSAO and 99mTc-AA5
uptake did not reach significant uptake. Black horizontal lines denote Kruskal-Wallis ANOVAs 1 Bonferroni correction, and red lines denote Wilcoxon
signed rank tests 1 Bonferroni correction. (d) Serial imaging revealed that 111In-GSAO uptake (top) was predominantly localized in the region of the
99mTc-MIBI perfusion defect (bottom). (e) c-counting of myocardial sections showed high 111In-GSAO uptake in sections with lowMIBI uptake and vice
versa. (f) A significant inverse Spearman’s correlation between uptake of 111In-GSAO and 99mTc-MIBI was observed. (g) Serial planar imaging in acuteMI
rabbit demonstrates similar uptake region and higher uptake of 111In-GSAO (top) when compared with 99mTc-AA5 (bottom). (h) c-counting of
myocardial sections showed high 111In-GSAO uptake in sections with high 99mTc-AA5 uptake and vice versa (i). A significant Spearman’s correlation
between uptake of 111In-GSAO and 99mTc-AA5 was observed.
www.nature.com/scientificreports
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SPECT/CT and planar imaging (Fig. 5c). Imaging experiments
revealed absence of specific 111In-GSAO uptake in control animals.
111In-GSAO uptake in the infarct area (2.566 2.75%ID/g) wasmark-
edly higher than in remote myocardium (0.48 6 0.22%ID/g, P 5
0.028) and 20-fold higher than apical uptake in unmanipulated con-
trol animals (n 5 5, 0.13 6 0.02%ID/g; p 5 0.004, Fig. 5d).
Radionuclide imaging in a post-MI HFmodel. 111In-GSAO uptake
was also evaluated in post-MI HF mouse model, in which the LCA
territory was not reperfused. Subgroups underwent imaging
experiments at different time points. Also, a disease control group
consisting of animals that did not undergo infarction surgery before
111In-GSAO imaging, and a radiotracer control group consisting of
animals receiving negative control compound 111In-GSCA imaging
at 2 weeks post-MI were used.
111In-GSAO uptake in the HF mice was markedly lower than in
AMI mice, and could not be detected by in vivo SPECT/CT imaging.
Quantification of radionuclide uptake in short axis slices con-
firmed that infarct uptake of 111In-GSAO in mice at 2 weeks post-
MI (n 5 6) was higher than in the five disease control animals that
did not undergo infarction surgery (0.42 6 0.17%ID/g vs 0.13 6
0.02%ID/g, P 5 0.025, Fig 6); remote uptake was not statistically
different (0.25 6 0.12%ID/g vs 0.14 6 0.04%ID/g, P 5 1.0, Fig 6).
Moreover, 111In-GSAOuptake at 2w post-MIwas significantly higher
than uptake of the negative control compound 111In-GSCA in the
infarct and remote area (0.04 6 0.02%ID/g, P , 0.001 and 0.04 6
0.03%ID/g, P 5 0.004, respectively).
Moreover, when compared with uptake at 2 weeks post-MI, 111In-
GSAO uptake showed a trend of decline at 4 weeks (n 5 6, infarct
0.286 0.09%ID/g, P5 1.0; remote 0.226 0.04%ID/g, P5 1.0, Fig 6)
and 12 weeks (n 5 8, infarct: 0.19 6 0.07%ID/g, P 5 0.332; remote:
0.15% 6 0.1%ID/g, P 5 1.0, Fig 6) although differences were not
statistically significant.
Discussion
Here we demonstrate cell death imaging in acute myocardial infarc-
tion using 111In-GSAO. The specificity of the radiotracer was con-
firmed by the localization of 111In-GSAO in the infarct zone as shown
by 99mTc-MIBI. This was further supported by the lack of uptake of
fluorescently labeled GSAO in sham-operated animals outside of the
regions directly damaged by the suture. The lack of GSCA uptake in
our radionuclide studies confirmed that the trivalent arsenic group
on GSAO is responsible for its targeting characteristics15,29,30. The
radiotracer showed favorable pharmacokinetic profile with rapid
blood clearance and low background uptake in most organs.
In the 1990’s evidence of apoptotic signaling in myocardial infarc-
tion accumulated19–22, sparking the discussion over the relative
importance of the apoptotic and necrotic forms of cell death. In
2000, 99mTc-AA5 SPECT in patients with acutemyocardial infarction
revealed intense uptake in the entire region of the perfusion defect5.
This observation was provocative as 99mTc-AA5 was believed to
identify apoptotic cell death but the infarct area was traditionally
Figure 4 | Histopathological characterization of 111In-GSAO uptake in rabbit heart after experimental acute myocardial infarction. H&E staining
demonstrates clear signs of tissue damage in infarct and border zone, whereas the remote zone is morphologically normal. TUNEL and Caspase-3 stains
demonstrate substantial apoptosis in the infarct zone, whereas positive cells are rarely seen in the remote area. Significant Spearman’s Rank correlations
between 111In-GSAO uptake and apoptotic signaling as shown by TUNEL (b) and Caspase-3 (c) stains were observed.
Figure 5 | In vivo and ex vivo 111In-GSAO imaging and quantification in
mice with acute myocardial infarction. In vivo SPECT (a), and fused
SPECT/CT images (b) in acute MI rabbits revealed intense cardiac 111In-
GSAO uptake. (c) Ex vivo planar images confirmed intense 111In-GSAO
uptake. (d) c-counting of myocardial sections confirmed 111In-GSAO
uptake in infarct (apex) was higher than manyfold higher than in remote
area and higher than apical 111In-GSAO uptake in unmanipulated control
animals. Black horizontal lines denoteMann-Whitney U tests and red lines
denote Wilcoxon signed rank tests.
www.nature.com/scientificreports
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expected to be necrotic. It was subsequently proposed that the
ischemic insult may be initiated as apoptosis but conclude with sec-
ondary necrosis. Ischemic loss of ATP production duringmyocardial
infarction would preclude completion of the energy-dependent
apoptosis program23. Restoration of blood flow by reperfusion may
either interrupt the apoptotic process to allow cell salvage6,24 or
resume the process of apoptosis in critically damaged cells20,22. The
latter may even be augmented further by production of radical oxy-
gen species25, or intracellular calcium overload26. These changes may
also contribute to secondary necrosis by opening of the mitochon-
drial permeability transition pore27–30. It is conceivable that the apop-
totic process initiated by noxious stimuli may not follow classical
picture of physiologic apoptosis observed during normal turnover
of skin or mucosal cells.
The feasibility of cell death imaging using fluorescently labeled
and radiolabelled GSAO has recently been demonstrated in tumor-
bearing mice and mice with experimental brain trauma13–15. GSAO
accumulation was characterized by fluorescent microscopy in vari-
ous cell models of apoptotic and in explanted brains and tumors after
in vivo GSAO administration. GSAO was observed intracellularly
and colocalized with propidium iodide and Sytox blue, standard
markers of membrane disruption, which supported GSAO uptake
in secondarily necrotic cells. Similarly, our fluorescent experiments
showed that GSAO accumulated intracellularly and only occurred in
AA5 1 cells, thereby supported the notion that necrosis followed
apoptotic signaling in the setting of acute myocardial infarction.
In vivo and ex vivo 111In-GSAO imaging in rabbits and mice with
acute myocardial infarction showed intense dual serial imaging with
99mTc-AA5 and 111In-GSAO in rabbits after acute myocardial ische-
mia and reperfusion revealed the same area of uptake. At a segment
level, 111In-GSAO uptake showed the same pattern as 99mTc-AA5 and
a strong correlation between uptakes of the two tracers was shown. In
addition, 111In-GSAO correlated with presence of Caspase-3 and
TUNEL staining, classic markers of apoptosis. This shows that not
only does secondary necrosis after apoptotic signaling occur in myo-
cardial ischemia and reperfusion, it may play a dominant role. As in
rabbits, high 111In-GSAO uptake was seen in mice with acute myo-
cardial infarction. However, 111In-GSAO uptake in post-myocardial
infarction HF model in mice was too low to be detected by micro-
SPECT/CT imaging. The most important explanation for this is the
lower rate of necrotic cell death in heart failure31–33. It is tempting to
speculate that the more benign circumstances such as lesser energy
depletion and ROS cause lower transition from apoptosis to necrosis
in this setting. In fact, the apoptotic process may remain suspended
in chronic heart failure34.
A number of imaging tracers for myocardial necrosis have been
clinically evaluated. Like 111In-GSAO, most tracers exploited mem-
brane disruption, the hallmark of necrosis as a target. Tc-99 labelled
antimyosin antibody was the most widely studied necrosis tracer.
Antimyosin antibody imaging has been successfully employed for
the detection of myocardial necrosis associated with myocardial
infarction9, myocarditis9, heart failure12 and cardiac allograft rejec-
tion12. However, because of long circulation time of the radiolabelled
antibody, imaging was not feasible for up to 6–12 hours after admin-
istration of the agent. 99mTc-pyrophosphate on the other hand,
showed maximal myocardial uptake at 24–72 hours after injection,
although necrosis imaging at 3 hours post-administration was feas-
ible, maximum myocardial uptake was at 24–72 h. Also, this tracer
required residual blood flow, which precluded uptake in the infarct
center35. 99mTc-glucarate can be used to necrotic cells in myocardial
infarction11,36, and has good imaging characteristics but in the setting
of myocardial infarction, use is limited to a clinical window of
.9 hours after onset as its target, histone bodies, quickly wash out
of the tissue11. Late gadolinium-enhanced MRI has also been used to
assess cardiac cell death; the contrast medium accumulates in nec-
rotic cells through the disrupted membranes. However, its specificity
is limited, as in all instances of increased extracellular space such as
cardiac edema, fibrosis, sarcoidosis and amyloidosis37–39. 111In-GSAO
appears to have advantages over the previously evaluated cell death
imaging techniques. First, 111In-GSAO requires membrane disrup-
tion, the hallmark of necrotic or late-apoptotic cell death, for reach-
ing its intracellular targets. Therefore it does not suffer from the lack
of specificity of late-gadolinium enhanced MRI. Moreover, its rapid
blood clearance results in feasibility of early imaging of cell death
using 111In-GSAO. This gives 111In-GSAO an advantage over 99mTc-
antimyosin and 99mTc-pyrophosphate. HSP90, the main target of
GSAO, functions in complexes. This may allow for targeting over a
longer time period, giving 111In-GSAO an edge over 99mTc-glucarate.
However, this has to be evaluated in follow-up studies.
Micro-SPECT/CT imaging using 111In-GSAO can be used to visu-
alize necrotic cell death in acutemyocardial infarction. The uptake in
the HF model was too low to allow imaging. Because the GSAO
uptake reflects membrane permeabilization, and occurs predomi-
nantly in AA5 positive cells, we propose that secondary necrosis is
a dominant mode of cell death in the setting of myocardial ischemia
and reperfusion.
Figure 6 | Quantification of 111In-GSAO uptake inmice with chronic myocardial infarction. C-counting revealed 111In-GSAO uptake in the infarct area
at 2 weeks; uptake was significantly higher than 111In-GSAO uptake in unmanipulated control animals and 111In-GSCA uptake at 2w post-MI in
controls. A trend of declining 111In-GSAO uptake over time was observed, but did not reach statistical significance. 111In-GSAO uptake in remote area was
higher than 111In-GSCA uptake at 2w post-MI. Results of Kruskal-Wallis ANOVAs 1 Bonferroni correction are shown.
www.nature.com/scientificreports
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Methods
Materials. Cy5.5 GSAO and DTPA-GSAO were prescribed as described previously13
and were a kind gift of Covidien Imaging Solutions (Hazelwood, Missouri, United
States). DTPA-GSAO and DTPA-GSCA were labeled with In-111 as described
previously13. The other used materials were of standard analytical grade.
Ethical statement. The experimental protocols followed the Guidelines for the Care
and Use of Laboratory Animals established by the National Institutes of Health (NIH
Publication No. 85–23, revised 1996) and was approved by the Institutional
Laboratory Animal Care and Use Committees at the University of California, Irvine
and University of Maastricht, Maastricht, The Netherlands.
Experimental myocardial infarction in mice. For fluorescence experiments,
C57Bl6/j (Age: 3 months, weight:,50 g, Jackson Laboratories, Sacramento, CA) and
for radionuclide studies Swiss-Webster mice (Age: 3 months, weight,50 g, Charles
River, Wilmington, MA) were used. MI was induced under isoflurane anesthesia (2–
3%) using a stereomicroscope (Leica MZ FL III, Leica, Switzerland) as described
previously40. Animals were placed on a heating pad in the supine position, intubated
under direct laryngoscopy, and mechanically ventilated using a small animal
respirator (tidal volume, 1.0 ml; rate, 120 breaths/min, Harvard Apparatus,
Holliston, MA). After a minimum thoracotomy, the anterior descending branch of
the left coronary artery was ligated with a 6.0-silk suture 3 to 4 mm below the tip of
the left atrium. Successful ligation was verified by visual inspection of the LV apex for
myocardial blanching, indicating interruption in coronary flow. For induction of
acuteMI experiments, the suturewas removed after 30minutes to induce reperfusion.
The sham operation was identical, but the coronary artery was not ligated. Acute MI
and sham animals remained under anesthesia for ensuing radionuclide imaging or
fluorescence experiments. For induction of chronic MI, the ligation was not released.
In these animals, the chest cavity was closed in layers with 6.0-silk and the skin was
closed with 4.0-silk sutures. Thereafter, animals were gradually weaned from the
respirator and put back into their cages until imaging procedure.
Experimental acute myocardial infarction in rabbits. Acute experimental MI was
induced by the occlusion of left anterior descending coronary artery (LAD) in New
Zealand White male rabbits (weight, 3.0–3.5 kg) as described previously24,41. All
rabbits were anesthetized with a mixture of ketamine and xylazine (100 mg/ml, 1051
vol/vol; 2.0 to 3.0 ml subcutaneously). Surgical tracheostomy was performed, and
ventilation was maintained with a volume-cycled rodent respirator (Harvard
Apparatus, Holliston, MA) provided positive pressure ventilation at 50 mL/cycle and
a respiratory rate of 50 cycles/min. After surgical procedure, anesthesia was
maintained on 3–4% isoflurane Briefly, the heart was exposed through parasternal
thoracotomy, and the pericardium was fenestrated. The LAD was identified and a
monofilament suture was placed at the site. The LAD was occluded by tightening the
snare created by passing suture through a polyethylene tube. The snare was removed
after 40 minutes of occlusion to induce reperfusion. Lead II or III of the
electrocardiogram was continuously monitored during the experiments to confirm
myocardial ischemia. Animals remained anesthetized for ensuing radionuclide
imaging experiments.
Fluorescence experiments in mice. Acute MI mice and sham-operated mice were
injected with Cy5.5-labelled GSAO at 5 minutes before ischemia and 1 hour before
sacrifice, respectively. All mice received Oregon Green-labeled AA5 10 minutes
before sacrifice. Of each fluorescent probe a dosage of 2.5 mg/kg was used. Acute MI
animals were sacrificed after 30 m reperfusion, sham mice at 1 hour after sacrifice
hearts were snap-frozen in liquid nitrogen, 7 mm thick frozen sections were obtained,
dried and mounted in 4,6-diamino-2-phenylindole (DAPI) containing medium and
examined with a confocal scanning laser microscope (Bio-Rad) equipped with a
krypton/argon mixed gas laser (Ion Laser Technology).
In vivo and ex vivo imaging protocols mice and rabbits. For mice and rabbits, the
same imaging procedure was followed. In vivo SPECT imaging was performed at
3 hours after radiotracer administration using a dual-head micro-SPECT c-camera
combined with micro-CT (X-SPECT, Gamma Medica, Inc., Northridge, CA) under
isoflurane anesthesia. SPECT images of the heart were acquired in a 643 64matrix at
32 steps at 60 seconds per step with a 247 keV photo peak of 111In with 15% windows
using a medium energy parallel-hole collimator. In the animals also undergoing
99mTc-MIBI 99mTc-AA5, this was followed by imaging using the same protocol, at a
140 keV photo peak of 99mTc with 15% windows using a low-energy, high-resolution
parallel-hole collimator. Gating was not performed. After SPECT imaging
acquisition, a CT scan was acquired using an X-ray tube operating at 50 kVp and
0.6 mA. Images were acquired for 2.5 seconds per view for 256 views in 360u rotation.
After transferring to 2563 256matrix, the SPECT images and CT studies were fused.
After imaging, anesthetized animals were terminated by heart explantation and ex
vivo SPECT/CT excised heart was performed using the same protocols but at 45
seconds per step for SPECT. Thereafter, planar 111In-GSAO imaging of the hearts was
performed for 15 minutes, followed by 99mTc-MIBI or 99mTc-AA5 planar imaging in
GSAO-MIBI and GSAO-AA5 animals. After ex vivo imaging, rabbit hearts were cut
into 4 short axis slices and further divided into 31-32 pieces. Mice hearts were cut in 3
short-axis slices. All sections were weighed, and c-counted in an automatic well-type
c-counter (Perkin Elmer Wallac Inc., Gaithersburg, MD) for calculation of the
percent total injected dose per tissue weight (%ID/g) uptake. Tissue samples of the
main organs were used for calculation of the %ID/g uptake to evaluate the bio
distribution. To correct for the radioactive decay and permit calculation of the
concentration of radioactivity as a fraction of the administered dose, aliquots of the
injected dose were counted simultaneously. For evaluation of infarct 111In-GSAO
uptake in rabbits, the section with the highest 111In-GSAO uptake in the infarct area
was used of each animal, and for evaluation of remote 111In-GSAO uptake, the section
with the lowest 111In-GSAO uptake in the remote area was selected. In all mice, the
apical slice was used for evaluation of infarct uptake, themiddle slice for uptake in the
border zone and the basal slice for remote uptake.
Pharmacokinetic studies. The pharmacokinetic parameters were derived using the
KINFIT module of the MW/PHARM computer program package (Version 3.60,
MediWare, Groningen, The Netherlands)42. The data, consisting of the blood
concentration of 111In radioactivity or GSAO versus time, were analyzed by non-
linear regression analysis using a least-squares weighted simplex algorithm, with data
weighted with the reciprocal of the observed value.
Histological, immunohistochemical evaluation. After c-counting of 111In-GSAO
uptake, myocardial pieces of seven rabbits were processed for histopathologic
characterization. Of each animal, two pieces from each region (infarct, border zone,
remote) were selected.
The myocardial pieces were fixed overnight 4% paraformaldehyde in PBS (pH 7.4
at 4uC), and stored in PBS with 0.02% sodium azide at 4uC until used. The specimens
were further processed by dehydration in a graded series of ethanol for paraffin-
embedding. The blocks were cut in 5-mm thick sections, floated on a water bath
containing deionized water (43uC), and transferred to vectabond (Vector
Laboratories Burlingame, California) reagent-treated slides (Vector SP-1800, Vector
Laboratories), dried overnight, and stored until ready for use. Sections were depar-
affinised by heating (25 minutes at 56uC) and dehydration using xylene and graded
series of ethanol. Tissue sections were stained with standard haematoxylin & eosin
and Masson’s trichrome staining. For immunohistochemical characterization, adja-
cent sections were incubated with primary antibodies against Caspase-3. After
washing with PBS, sections were incubated with a biotinylated secondary antibody.
The presence of apoptotic cells was further evaluated using TUNEL staining as
described previously. Briefly: exposed DNA fragments were labeled with biotinylated
nucleotides (dNTPs) and TdT for 1 h at 37uC after blocking of endogenous perosi-
dase activity using 0.3%hydrogen peroxide and incubation with proteinase K41. For
color reactions, sections were incubated with diaminobenzidine. For the assessment
of the immunopositive area, stained tissue sections were observed under appropriate
magnification (Carl Zeiss, Thornwood, New York), and the images were captured
with a high-resolution digital camera (Axiocam, 1,300 3 1,030 pixels, Carl Zeiss)
using Axiovision 3.1 software. Digital images were analyzed using Image-Pro Plus 5.0
(Media Cybernetics, Bethesda, Maryland).
Statistical analysis. All results are presented as the mean 6 SD. In most cases, the
data did not meet the assumptions of parametric tests. For consistency, non-
parametric tests were used for all comparisons. Related samples were compared using
Wilcoxon Signed Rank test (two groups) or Friedman’s Two Way ANOVA followed
by post-hoc Wilcoxon Signed-Rank tests and Bonferroni correction for pair-wise
significance (more than two groups). Unrelated samples were compared using Mann
Whitney U tests (two groups) or Kruskal-Wallis ANOVA followed by Mann-
Whitney U tests and Bonferroni Correction for pair-wise significance (more than two
groups). When the Kruskal-Wallis test revealed no significant differences among
groups, no post-hoc tests were performed and P 5 NS was reported. Bonferroni
correction was also applied to results of multiple Wilcoxon signed rank tests
regarding the uptake of radiotracers in infarct vs. remote areas in rabbits (fig 3c). To
assess the correlation between 111In-GSAO uptake and 99mTc-AA5 uptake, 99mTc-
MIBI uptake and histologic findings (caspase-3 and TUNEL), Spearman’s rs were
calculated. P values of ,0.05 were considered statistically significant.
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